Purchase Order 75N91023P00585
Award Date 7/20/23
Potential Completion Date 7/19/24
Potential Value $15K
Federal Agency
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
North Bethesda, MD 20852, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $12,248 purchase order to Sartorius Corporation for a service agreement and warranty for the IncuCyte S3 system. Under this firm fixed price contract, Sartorius Corporation Division will provide support and maintenance services for the IncuCyte S3 live-cell analysis instrumentation from November 2023 through April 2024 at its Rockville, Maryland location. No subcontractors or set...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed price purchase order to Sartorius Corporation valued at fourteen thousand five hundred forty-four dollars and fifty-two cents ($14,544.52) to cover a Sartorius IncuCyte system under a service contract for the agency's Genetics Branch. Performance will take place from November 24, 2023 through November 23, 2024 at the agency's campus in Bethesda, Maryland. No set-aside...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $14,544.50 firm fixed price purchase order to Sartorius Corporation for preventative maintenance and service of an IncuCyte S3. Sartorius Corporation, a division of Sartorius Aktiengesellschaft, will provide the requested products and services at a location in Bethesda, Maryland through November 2024. The award utilizes a National Institutes of Health contract vehicle to procure services...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $30,667.90 firm fixed price purchase order to Sartorius Corporation for maintenance of two Sartorius Incucytes S3S owned by the government. Sartorius Corporation, a division of Sartorius Aktiengesellschaft, will provide maintenance services for the Incucytes located in Bethesda, Maryland over a one year period from September 2023 through September 2024. No subcontractors or set aside...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $19,570 firm fixed price purchase order to Sartorius Corporation. Sartorius Corporation, a division of Sartorius Aktiengesellschaft, will provide products or services to the National Cancer Institute in Bethesda, Maryland over a one year period ending in November 2024. As the National Cancer Institute supports cancer research, this contract is likely to supply laboratory materials,...
- Sartorius Corporation has been awarded a firm fixed price purchase order totaling $14,900 by the Department of Health and Human Services' National Institutes of Health National Cancer Institute. The contract is for service of the agency's IncuCyte S3 live-cell imaging system located in Bethesda, Maryland, with a period of performance through March 2025. As a manufacturer of laboratory equipment and provider of services to the biopharmaceutical and research industries, Sartorius Corporation...
- The National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, awarded a $15,656.00 firm-fixed-price purchase order to Sartorius Corporation, a foreign-owned, for-profit manufacturer of laboratory equipment and solutions. The service contract is for the Sartorius Incucyte S3, a live-cell analysis system used to support the NCI's biomedical research and development initiatives, particularly in areas such as infectious diseases, cancer, and drug...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a one-year, firm fixed price purchase order valued at approximately $17,632 to Sartorius Corporation for maintenance services. As the prime contractor, Sartorius Corporation Division will perform the required maintenance work itself from its location in Bohemia, New York. The contract is funded through the National Cancer Institute to support its research efforts and will run from...
- This $15,656.00 firm-fixed-price purchase order was awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Sartorius Corporation, a foreign-owned, for-profit manufacturer of laboratory equipment and solutions. The contract is for a service agreement with a period of performance through September 9, 2025. Sartorius Corporation, which is primarily a supplier of advanced biomedical instruments, consumables, software, and associated...
- This is a firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Sartorius Corporation, a foreign-owned, for-profit manufacturer of laboratory equipment and solutions. The $15,969.40 contract is for a service agreement to provide the NCI with the S3 IncuCyte live-cell analysis system, which supports cutting-edge biomedical research across infectious diseases, cancer studies, and translational sciences....
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $14,544.60 firm fixed price purchase order to Sartorius Corporation for a SERVICE AGREEMENT OF INCUCYTE S3 SW/SVC. Sartorius Corporation, a division of Sartorius Aktiengesellschaft, will provide the requested products and services from their Rockville, Maryland location of performance over a one year period ending in July 2024. No set aside designation or major subcontractors were indicated. The contract supports the National Cancer Institute's efforts to advance cancer research through the provision of IncuCyte S3 software and services.
Generated 12/20/23, 4:41 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.5k | 6/29/23 |